Calculating the Costs Attributable to Risk Factors for Cancer
Damage-associated molecular patterns (DAMPS) as mediators of injury in patients receiving induction chemotherapy for AML
Carlos E. Vigil, M.D., Clinical Fellow of Hematopoietic Stem Cell Transplant at Vanderbilt–Ingram Cancer Center. Lunch will be provided.
Moving Internet-delivered interventions from RCT to real-world dissemination: Challenges, lessons learned, and plans for the future
Lee Ritterband, PhD, Professor and Frances Thorndike, PhD, Assistant Professor, Psychiatry and Neurobehavioral Sciences, University of Virginia
Featuring: Thomas Jessell, PhD, 2009 Perl-UNC Neuroscience Prize Winner, Professor, Columbia University, Department of Biochemistry and Molecular Biophysics
William B. Coleman, PhD, Professor, Pathology and Laboratory Medicine, Curriculum in Toxicology, Program in Translational Medicine, UNC Lineberger Cancer Center Carey K. Anders, MD, Associate Professor of Medicine, Division of Hematology Oncology, UNC Lineberger Cancer Center
Sidi Chen, PhD, Koch Institute, Department of Biology, Massachusetts Institute of Technology
Himisha Beltran, MD, Assistant Professor of Medicine, Weill Conrell Comprehensive Cancer Center
The Atherosclerosis Risk in Communities (ARIC) Study and Outcomes Research
Nilu Goonetilleke, Ph.D., UNC Chapel Hill
Cancer Outcomes Seminar Series: Albert Wu, Center for Health Services and Outcomes Research, Johns Hopkins University
"Attack of the PROs – How PCOR is Subverting the Clinical Research"